My Favorite Biotech Stock for 2021
Biotechs have consistently dominated the list of best-performing stocks over the past two decades. A whopping 32 biotech equities, for instance, generated returns in excess of 300% in 2020. Perhaps the most attractive part of this powerful trend for investors is that several of these companies weren't so-called COVID-19 plays, either. As just one example, Cardiff Oncology, a clinical-stage cancer specialist, produced a jaw-dropping 1,400% return on capital over the whole of 2020.
Which biotech stocks are poised for rocket-like growth in 2021? I have my eye on several names as the new year opens, but my favorite name in biotech this year is Trillium Therapeutics (NASDAQ: TRIL). Here's why I think this small-cap biotech could be a big winner in 2021.
Image source: Getty Images.
Source Fool.com